Terminated PHASE1 INTERVENTIONAL 2-arm NCT05177029

Safety and Tolerability Study of Lu AG06466 in Healthy Young Japanese and Caucasian Participants

Interventional, Randomized, Double-Blind, Sequential-Part, Placebo-Controlled, Single- and Multiple-Dose Study Investigating Safety, Tolerability, and Pharmacokinetic Properties of Lu AG06466 in Healthy Young Japanese and Caucasian Subjects

Sponsor: H. Lundbeck A/S

Conditions Healthy Volunteers

Interventions Lu AG06466 Placebo

Updated 4 times since 2022 Last updated: Jul 8, 2022 Started: Nov 26, 2021 Primary completion: Dec 29, 2021 Completion: Dec 29, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated for strategic reasons.

Other terminated trials from H. Lundbeck A/S

See all terminations from H. Lundbeck A/S

Other Healthy Volunteers trials with similar outcome

Browse all Healthy Volunteers trials

A PHASE1 clinical study on Healthy Volunteers, this trial is terminated or withdrawn. The trial is conducted by H. Lundbeck A/S and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Sep 2022 — Jul 2024 [monthly]

Terminated PHASE1

Status: Recruiting → Terminated
Jan 2022 — Sep 2022 [monthly]

Recruiting PHASE1

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

H. Lundbeck A/S

Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yokamachi Hachioji City, Japan